Kontrol Energy Files Patent Applications With the U.S. Patent and Trademark Office and the Canadian Intellectual Property Office for Its Biocloudtm Technology
Kontrol Energy Corp. (CSE:KNR, OTCQB:KNRLF) announced the filing of four patent applications for its BioCloud Technology, aimed at detecting airborne pathogens. Three applications were submitted to the U.S. Patent and Trademark Office and one to the Canadian Intellectual Property Office. The BioCloud technology utilizes continuous air quality monitoring and a detection chamber to enhance air safety in shared spaces. CEO Paul Ghezzi emphasized the company's commitment to innovation. However, the technology is not a medical device and does not claim to eliminate COVID-19.
- Filing of four patent applications enhances intellectual property portfolio.
- BioCloud technology aims to improve air quality and safety in communal spaces.
- BioCloud is not a medical device and cannot claim to detect or eliminate COVID-19.
- Successful development of BioCloud is uncertain and hinges on regulatory approvals.
TORONTO, ON / ACCESSWIRE / November 30, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") a leader in smart buildings and smart cities through IoT, Cloud and SaaS technology is pleased to announce that as a follow up to its press release dated September 23rd, 2020, the Company has filed four patent applications for its BioCloudTM Technology.
Four patent applications have been filed, three with the U.S. Patent and Trademark Office and one with the Canadian Intellectual Property Office : SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS.
"These patent applications address key attributes of our technology, which utilizes a combination of continuous air quality monitoring and a proprietary detection chamber to target and identify airborne pathogens to help create safer spaces," says Paul Ghezzi, CEO Kontrol. "We are very proud of our team and the milestone this represents. Innovation is at the core of our operations and we continue to execute on our plans."
About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in smart buildings and smart cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware and service solutions to its customers to improve energy management, air quality and deliver continuous emission monitoring.
Additional information about Kontrol Energy Corp. and BioCloud can be found on its websites at www.kontrolenergy.com and www.kontrolbiocloud.com, and by reviewing its profile on SEDAR at www.sedar.com
For further information, contact:
Paul Ghezzi, Chief Executive Officer
paul@kontrolenergy.com or admin@kontrolenergy.com
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company's product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer (BioCloud) are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol's lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
SOURCE: Kontrol Energy Corp.
View source version on accesswire.com:
https://www.accesswire.com/618743/Kontrol-Energy-Files-Patent-Applications-With-the-US-Patent-and-Trademark-Office-and-the-Canadian-Intellectual-Property-Office-for-Its-Biocloudtm-Technology
FAQ
What is the significance of Kontrol Energy's recent patent applications?
What does the BioCloud technology do?
Is BioCloud effective against COVID-19?
What risks are associated with Kontrol Energy's BioCloud technology?
